| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.00048 | 1 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.00049 | 1 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.0005 | 1 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.00043 | 1 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.0004 | 1 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.00089 | 1 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.00035 | 1 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.00035 | 1 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.0003 | 1 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.00027 | 1 |